Office Depot, Inc. (NASDAQ:ODP) trading capacity remained 4.77 million shares during the last session. However, the volume average of the last three months is 7.67 million shares. The stock opened the day at $2.66, and settled at $2.7 by the end to experience a 1.5% change.Office Depot, Inc. (ODP) Analyst Opinion
Office Depot, Inc. has a consensus hold rating from 7 Wall Street analysts, and the number of shares currently sold short amount to at least 4.52% of shares outstanding. The stock sank -2.53% last month and is down -23.73 this year. Wall Street is only getting more bearish on the stock, with 1 of analysts who cover ODP having a buy-equivalent rating. Analysts have placed a $2.91 price target on Office Depot, Inc., suggesting a 7.78% gain from recent close. It’s currently trading about -56.83% below its 52-week high.
Office Depot, Inc. (ODP) failed to surprise the stock market in its last reported earnings when it earned $0.08 a piece versus the consensus-estimated $0.08. Its revenue totaled $2.72 billion up 5.42% from the previous quarter.Office Depot, Inc. (NASDAQ:ODP) Intraday View
This stock (ODP) is ahead of its 52-week low with 35%. Its last month’s stock price volatility remained 4.22% which for the week stands at 4.31%. The share price has moved backward from its 20 days moving average, trading at a distance of -4.15% and stays 5.87% away from its 50 days moving average. Over the last five days, shares have managed 1.5% gains and now is down -10.17% since hitting its 200-day moving average of $2.73. Office Depot, Inc. (ODP) has made its way to a 12-month decline of -51.44%.
Turning to Onconova Therapeutics, Inc. (NASDAQ:ONTX), its shares were trading at $0.44 a retreat of $-0.02, on the trading floor. The stock, after opening at $0.446, touched a high of $0.478 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Onconova Therapeutics, Inc. has 0 buy ratings, 0 holds and 0 sells even after the stock tumbled -84.43% from its high of $2.83 to a $37.85 million market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 2 to 2 during a month. Analysts set a 12-month price target of $3.45 a share. The target implies a 684.09% spike from where the shares are currently trading. Also, the current price highlights a discount of 581.82% to analysts’ high consensus price target.
The counter witnessed a trading volume of 0.82 million shares versus an average volume of 2.53 million shares during last trading session. Its last month’s stock price volatility remained 12.2% which for the week approaches 13.87%. The lowest price the stock reached in the last trading day was $0.4187 and compares with the $0.33 52-week low. The stock recovered 33.28% since its low point and has performed -70.63% year-to-date.